Robert Nelson, DO
Physical Medicine & Rehabilitation · Scottsbluff, NENPI 1083931877
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 28.8% of the total.
Across 60 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$276
- Amneal Pharmaceuticals LLC$198
- Amgen$59
- Lundbeck LLC$46
- Teva Pharmaceuticals USA, Inc.$43
- AstraZeneca$42
- plus $294 from 12 others
What the payments were for
- Food & beverage$958100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $276 |
| Amneal Pharmaceuticals LLC | 11 | $198 |
| Amgen | 4 | $59 |
| Lundbeck LLC | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| AstraZeneca | 3 | $42 |
| EMD Serono, Inc. | 3 | $41 |
| UCB, Inc. | 3 | $39 |
| Sanofi | 2 | $31 |
| Biogen | 2 | $28 |
| Lilly USA, LLC | 2 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| CSL Behring | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| GE HealthCare | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Adamas Pharmaceuticals, Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
How this compares
$958 in reported general payments places this provider in the 75th percentile of 57 physical medicine & rehabilitation providers in Nebraska.
See all physical medicine & rehabilitation providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 200 | $4,132 |
| FioricetButalb/Acetaminophen/Caffeine | 15 | $1,870 |
| Methylphenidate ErMethylphenidate Hcl | 25 | $555 |
| Modafinil | 14 | $389 |
| Tizanidine Hcl | 33 | $368 |
| Gabapentin | 43 | $300 |
| Primidone | 12 | $244 |
| Meloxicam | 13 | $135 |
| Atorvastatin Calcium | 17 | $110 |
| Amlodipine Besylate | 11 | $77 |
| Tamsulosin Hcl | 13 | $54 |
| Trazodone Hcl | 12 | $39 |
| Tramadol Hcl | 17 | $31 |
| Finasteride | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Scottsbluff
- Masumi WilroyScottsbluff$698
- Leslie CavazosScottsbluff$310
- Kurt GoldOmaha$8K
- Daniel WikColumbus$8K
- Jeremy GallantOmaha$2K
- David DiamantLincoln$2K
- Bo CuiOmaha$2K
- Thomas FrancoOmaha$2K
- Jiaxin TranLincoln$2K
- Adam KafkaLincoln$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.